コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 risk of the emergence of treatment-resistant mutant virus.
2 but not CLDN1, were infectable only with the mutant virus.
3 nd the infectivity of a class II IN deletion mutant virus.
4 genetically engineered CTL epitope-deficient mutant virus.
5 ouse studies show extreme attenuation of the mutant virus.
6 ored replication and virulence of the dNSP16 mutant virus.
7 in RAL IC50 than that of the IN-G140S/Q148H mutant virus.
8 s recruited in the airways compared with the mutant virus.
9 ited higher infectivity than either parental mutant virus.
10 dly diminished in cells infected with EBNA3A mutant virus.
11 the acquisition of transmissibility by this mutant virus.
12 liver in comparison to those produced by the mutant virus.
13 lial cells following infection with the UL78 mutant virus.
14 ntly decreased following reactivation of the mutant virus.
15 genes) or after infection with the DeltaICP0 mutant virus.
16 tly delayed in cells infected with the pUL25 mutant virus.
17 HA) mRNA nuclear export was seen with an NS1 mutant virus.
18 RNA in virions of wild-type, but not escape mutant, virus.
19 y to evaluate the antigenic phenotype of the mutant viruses.
20 athology following intranasal infection with mutant viruses.
21 multiple mutations were less fit than single-mutant viruses.
22 teracting with the MAbs, we generated escape mutant viruses.
23 d in cells infected with wild-type and ORF12 mutant viruses.
24 from mice infected with wild-type or glycan mutant viruses.
25 nds, the attenuated VACV was replaced by the mutant viruses.
26 e characteristics were unchanged for the two mutant viruses.
27 study, confirmed potency and selectivity of mutant viruses.
28 a dominant-negative, deacetylase-dead point mutant virus (AAV-HDAC3(Y298H)-v5), we found that select
29 press the DUB mutant and showed that the DUB mutant virus activated an earlier type I interferon resp
31 reated or IFN-treated cells infected by this mutant virus (AdEasyE1Sub19) contained much higher stead
32 we engineered a recombinant KSHV ORF52-null mutant virus and found that loss of ORF52 results in red
33 Using reverse genetics, we engineered Ubl mutant viruses and found that AM2 (V787S) and AM3 (V785S
35 Since wt virions could not complement the mutant viruses, and the mutant viruses did not effective
36 and most viral gene expression of the L4-33K mutant virus are comparable to those of the wild-type vi
37 e not required for effective host control of mutant virus as all N1347A virus-infected mice survived
38 ectron microscopy to reveal that the gH-null mutant virus assembled and exited from cells normally, c
39 eceptor homolog, with the infectivity of one mutant virus being >500-fold less with the quail TVA rec
42 of PACT compromised IFN-I activation by the mutant virus, but not wild-type virus, a finding consist
43 ile in IFN-deficient Vero cells, both WT and mutant viruses can replicate at relatively high levels.
45 us in virus-specific antiserum gives rise to mutant viruses carrying mutations A125T+A151T+L217Q in t
46 re explained in part by the observation that mutant viruses carrying NNRTI plus INSTI resistance muta
49 ated from lesions of animals inoculated with mutant virus contained mutations in the area of 3A that
53 ing the latency-reactivation cycle because a mutant virus containing stop codons at the amino terminu
54 tal virus, SAT2/ZIM/7/83, indicated that the mutant virus containing the TQQS-to-ETPV mutation in the
55 In vitro susceptibility measurements with mutant viruses containing amino acid substitutions K70G,
56 infection of JCPyV by generating a panel of mutant viruses containing amino acid substitutions of th
57 ortant for these cellular processes and that mutant viruses containing mutations of CrPV-1A attenuate
58 in autophagic responses to wild-type or F17 mutant viruses could be detected, with autophagic activi
60 owth of a B1-deficient temperature-sensitive mutant virus (Cts2 virus) in U2OS osteosarcoma cells.
61 hree antibodies had neutralizing activity to mutant viruses deficient in gp41 carbohydrate attachment
63 of IFN-alpha/betaR-/- mice with the G50DblKo mutant virus demonstrated partial rescue of (i) acute vi
64 that recombinant E119D and E119A/D/G/-H274Y mutant viruses demonstrated reduced inhibition by all of
65 s; further, the recombinant T205-substituted mutant viruses described here would appear to be the fir
67 nduced by infection with an E1B 19K deletion mutant virus did not repress macrophage proinflammatory
68 d not complement the mutant viruses, and the mutant viruses did not effectively inhibit wt gene expre
69 onotic potential; however, the wild-type and mutant viruses did not replicate to high titers in all i
71 ntly, compared with the wild-type virus, the mutant virus displayed a decreased capacity to infect an
75 re, we show that pro-necrotic murine CMV M45 mutant virus drives virus-induced necroptosis during non
76 the replication and pathogenesis of the DUB mutant virus (DUBmut) in cultured macrophages and in mic
81 TB reaction pharmacologically or by using a mutant virus enhanced or inhibited transmission, respect
83 ere, we demonstrate that in U2OS cells, a B1 mutant virus escapes the block in DNA replication observ
90 rus-infected controls, animals infected with mutant virus exhibited higher viral load in cerebrospina
91 Correspondingly, the ORF64 DUB active site mutant virus exhibited impaired ability to establish lat
93 wer-fidelity W237I (W237I(LF)) and W237L(LF) mutant viruses exhibited lower ribavirin resistance.
95 erved in other cell types and, instead, this mutant virus exhibits impaired late protein accumulation
99 s or in the livers of infected mice, whereas mutant viruses expressing inactive VP3-CTD (H718A or H79
100 l of vIL-6 variants and utilization of HHV-8 mutant viruses expressing selected variants in phenotypi
101 However, unlike the wild-type virus, the mutant virus failed to enter into the axoplasm of gangli
103 mapping of the neutralizing mAbs via escape mutant virus generation revealed a shared binding epitop
106 In both cell culture and mosquitoes, the mutant viruses grew equivalently and did not revert to w
110 tinocytes infected with wild-type but not E7 mutant virus had perturbed transcriptional regulation of
112 Likewise, the RT-E138K plus IN-G140S/Q148H mutant virus had significantly greater fold increases in
114 S/Q148H and the RT-E138K plus IN-G140S/Q148H mutant viruses had significantly greater fold increases
116 ximately 51-nucleotide contiguous subsegment mutant viruses having synonymous mutations revealed that
119 s improved the fitness of the IN-G140S/Q148H mutant virus in the presence of raltegravir (RAL); the R
120 support spread of progeny virus was an HAdV3 mutant virus in which formation of PtDd was disabled (mu
121 e than WT viruses in vivo Replication of P50-mutant viruses in an APOBEC3-expressing stable cell line
123 hout infection with either wild-type or ICP0 mutant viruses in human embryonic lung cells (HEL) or HE
125 assessed the stability of the 18 recombinant mutant viruses in regard to their growth kinetics, antig
126 the HA stalk can lead to expansion of escape mutant viruses in study participants challenged with a 2
128 n gene expression elicited by the native and mutant viruses in the lungs of infected mice were determ
136 the nucleus is severely compromised in UL92 mutant virus-infected cells, and mature virions are not
140 ages is dramatically increased during double-mutant virus infection and correlates with faster antivi
141 f UV treatment, lentivirus transduction, and mutant virus infection experiments, our results demonstr
143 e CTV, which correlated with invasion of the mutant virus into the immature xylem tracheid cells and
146 mice with WT or AM2 virus and found that the mutant virus is highly attenuated, yet it replicates suf
149 can partially complement a growth-defective mutant virus lacking both UL21a and UL97, with significa
152 a novel approach that employs HCMV deletion mutant viruses lacking HLA class I immunoevasins and all
154 deletions in the CT, we were able to rescue mutant viruses lacking two or four residues (rDelta2 and
155 3 inhibitor, GSK872, and infection with this mutant virus led to phosphorylation and aggregation of M
156 restore infectivity to maturation-defective mutant viruses led us to hypothesize that SP may play an
160 dilated cardiomyopathy, suggesting that such mutant viruses may be the forms responsible for persiste
161 asmid (McKbac) and utilized to construct the mutant virus McK(gKDelta31-68), carrying a 37-amino-acid
162 viruses, we found that APOBEC3 restricts the mutant viruses more than WT viruses in vivo Replication
164 of mice with the macrodomain catalytic point mutant virus (N1347A) resulted in reductions in lethalit
166 iii) that in cells infected with a DeltaICP0 mutant virus, Nectin-1 remained on the cell surface.
167 -KO Huh-7.5 cells supported infection by the mutant virus only when CLDN1, CLDN6, or CLDN9 was expres
169 The defects in assembly of gE(-) US9(-) mutant virus particles were novel because they were neur
173 C terminus of the V gene in PIV5 results in mutant viruses (PIV5DeltaSH and PIV5VDeltaC) that enhanc
176 protect mice against lethal challenge of the mutant viruses, possibly owing to its ability to mediate
177 veolar lavage fluid after infection with the mutant virus PR8 A/NS1-Y89F (PR8 Y89F) when compared wit
178 ar clone JFH-1, thereby producing a range of mutant viruses predicted to possess altered RNA secondar
182 ing of this mutant confirmed the presence of mutant virus protein in the transfected BHK cell lysate.
188 npermissive for VACV; however, wild-type and mutant viruses replicated in triple-KO cells in which RN
193 -resistant C57BL/6 mice with a CrmD deletion mutant virus resulted in uniform mortality due to excess
197 isolate with a US17 deletion (the DeltaUS17 mutant virus) revealed blunted host innate and interfero
198 context of cells infected with wild-type or mutant virus, reversing the charge of these two residues
199 However, in the majority of the animals, the mutant virus reverted back to the wild-type sequence, he
201 ately twice as many upregulated genes in the mutant virus samples by 48 h postinfection, despite iden
202 dicating that cells infected with a UL97-L1m mutant virus show no defects in growth or E2F-responsive
203 to the wild-type virus, the ToV-PLP knockout mutant virus showed impaired growth and induced higher e
205 restingly, in mice the neutralization escape mutant viruses showed either attenuation (Urbani backgro
207 Upon infection of guinea pigs, the RNase mutant viruses stimulate strong IFN responses, fail to r
208 The recombinant A/Puerto Rico/8/34 (rPR8) mutant virus strain was attenuated and caused reduced mo
210 , and RFC5 mRNAs also enhanced spread of the mutant virus, strengthening the biological significance
211 , amantadine and rimantadine, while the S31N mutant viruses, such as the pandemic 2009 H1N1 (H1N1pdm0
212 ters in the brains of mice infected with the mutant virus suggest that the alphavirus TF protein is i
213 a clinically relevant dolutegravir resistant mutant virus suggesting potential clinical benefits for
214 escued the virulence of the PP1alpha-binding mutant virus, suggesting an IFN-independent role for eIF
215 lls infected with a newly isolated UL32-null mutant virus, suggesting that UL32 acts as a chaperone c
216 le in cells infected with E1B-55K or E4-ORF6 mutant viruses, suggesting that Ad regulates paralog-spe
217 teraction did not affect the HA titer of the mutant viruses, suggesting that the same amount of viral
221 y as the wild-type virus; however, the smD1' mutant virus that does not express NS2 and NS4 underwent
223 ine expressing A30.5, we isolated a deletion mutant virus that exhibits a defect in morphogenesis in
224 g its performance in samples infected with a mutant virus that fails to block transcription terminati
227 ere, by using the previously described Q129H mutant virus that selectively lacks DNase activity but r
232 mutant, wild-type, and HA-H241Q and HA-K582I mutant viruses that have HA activation pH values of 6.3,
235 h wild-type H18N11 leads to the emergence of mutant viruses that lack the N11 ectodomain and acquired
236 of action of these inhibitors, we generated mutant viruses that were resistant to the inhibitory eff
237 o AD-5 and neutralization activity toward gB mutant viruses that were similar to those of AD-5-specif
239 increases neutralization sensitivity of the mutant virus to CD4 binding site (CD4bs)-directed antibo
240 We generated and characterized an Ad5 L4-33K mutant virus to further explore its function(s) during i
241 V reverse genetics, we generated a series of mutant viruses to define the contributions of macrodomai
242 dergo continual antigenic evolution allowing mutant viruses to evade host immunity acquired to previo
243 stigate the potential threat of serum escape mutant viruses to humans and poultry, the impact of thes
244 MDC-mediated capture and transmission of MA mutant viruses to T cells were decreased, suggesting tha
245 antly, we show that the macrodomain and PLP2 mutant viruses trigger production of type I interferon i
246 t of WT virus revealed that the destabilized mutant virus triggered the upregulation of more host gen
249 We observed that each individual escape mutant virus was able to avoid neutralization by its res
250 MHV68 G50DblKo virus demonstrated that this mutant virus was able to establish latency in the spleen
251 AR1-sufficient CON(kd) cells, only the C(ko) mutant virus was an effective inducer and the IFN-beta R
256 nce of EFV, the RT-E138K plus IN-G140S/Q148H mutant virus was fitter than one with the RT-E138K mutat
261 ependent on the viral protein NSs, as an NSs mutant virus was not found to induce the equivalent sign
264 ingle-cycle (DISC) vaccine strategy, a GPCMV mutant virus was used that lacked the ability to express
265 at the membrane fusion step, and while this mutant virus was viable, it was significantly attenuated
268 the replication of the S224A and S224A/T226A mutant viruses was reduced in cell culture and in vivo.
269 onoclonal antibody inhibition and a deletion mutant virus, we demonstrate that the KSHV virion glycop
272 verity and lethality caused by the different mutant viruses, we have identified specific residues loc
273 ncing of cyclophilin A (CypA), as well as CA mutant viruses, we implicated CypA in the SUN2-imposed b
276 rse transcription reactions of the glyco-Gag mutant virus were substantially inhibited compared with
277 als, whereas the NA-T342A and NA-F144C/T342A mutant viruses were detected in the nasal turbinates, in
278 of the F proteins expressed by the recovered mutant viruses were efficiently cleaved and transported
282 24)LL3D(YR) and double A(24)LL3B(PVKV)3D(YR) mutant viruses were markedly attenuated upon inoculation
284 tly infected mice, although F1, F2 and F1/F2 mutant viruses were rapidly eliminated 1-7 days post-ino
288 cine, based on a replication-defective HSV-2 mutant virus, which has been recently tested in clinical
289 address this question, we took advantage of mutant viruses whose viral entry into cells relies on th
294 cal for the induction of T-cell lymphomas as mutant viruses with precise deletions were significantly
296 NY99 or Eg101 strain (NY-WT or EgCME-WT) and mutant viruses with substitutions of amino acid 159 of t
298 in the viral polymerase (L protein) of most mutant viruses, with the vast majority of the amino acid
299 e the wild-type virus, it can also bind to a mutant virus without inhibiting fusion or attachment.